Cellular Uptake of the Tyrosine Kinase Inhibitors Imatinib and AMN107 in Gastrointestinal Stromal Tumor Cell Lines

Publisher： Karger

E-ISSN： 1423-0313|77|1|11-16

ISSN： 0031-7012

Source： Pharmacology, Vol.77, Iss.1, 2006-05, pp. : 11-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activity of Nilotinib (AMN-107) Alone in Advanced Gastrointestinal Stromal Tumors Progressing on Imatinib and Sunitinib

By  

Chemotherapy, Vol. 55, Iss. 2, 2009-02 ,pp. : 132-136

Karger

Access to resources Recommend Favorite

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients

By Semeniuk-Wojtaś Aleksandra   Lubas Arkadiusz   Stec Rafał   Szczylik Cezary   Niemczyk Stanisław  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-12 ,pp. : 2073-2073

MDPI

Access to resources Recommend Favorite

Synergism of Cyclin-Dependent Kinase Inhibitors with Camptothecin Derivatives in Small Cell Lung Cancer Cell Lines

By Hamilton Gerhard   Klameth Lukas   Rath Barbara   Thalhammer Theresia  

Molecules, Vol. 19, Iss. 2, 2014-02 ,pp. : 2077-2088

MDPI

Access to resources Recommend Favorite

Therapeutic Innovations: Tyrosine Kinase Inhibitors in Cancer

By Dervisis Nikolaos   Klahn Shawna  

Veterinary Sciences, Vol. 3, Iss. 1, 2016-01 ,pp. : 4-4

MDPI

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma

By Ribatti Domenico  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1225-1231

MDPI

Access to resources Recommend Favorite